Alembic Pharmaceuticals Receives USFDA provisional Approval for Bosutinib Tablets
312 days ago
Alembic Pharmaceuticals Announced that it had received provisional Approval from the USFDA for Bosutinib Tablets that is used for cancer t....
Get the latest Alembic Pharmaceuticals stock market news, including real-time updates, detailed analysis, and insights from financial experts. Stay ahead in the market with our comprehensive coverage.
312 days ago
Alembic Pharmaceuticals Announced that it had received provisional Approval from the USFDA for Bosutinib Tablets that is used for cancer t....
318 days ago
Alembic Pharmaceuticals reports an 80% surge in net profit for FY24, rising from ₹342 crore to ₹616 crore, driven by operational efficiencie....
325 days ago
USFDA gives the nod to Icatibant Injection Drug of Alembic Pharmaceuticals which will be used to treat the hereditary angioedema (HAE)....